These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 11123327)
21. Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Oliveira GA; Wetzel K; Calvo-Calle JM; Nussenzweig R; Schmidt A; Birkett A; Dubovsky F; Tierney E; Gleiter CH; Boehmer G; Luty AJ; Ramharter M; Thornton GB; Kremsner PG; Nardin EH Infect Immun; 2005 Jun; 73(6):3587-97. PubMed ID: 15908388 [TBL] [Abstract][Full Text] [Related]
22. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309 [TBL] [Abstract][Full Text] [Related]
23. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice. Perlaza BL; Sauzet JP; Balde AT; Brahimi K; Tall A; Corradin G; Druilhe P Eur J Immunol; 2001 Jul; 31(7):2200-9. PubMed ID: 11449374 [TBL] [Abstract][Full Text] [Related]
24. Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate. Milich DR; Hughes J; Jones J; Sällberg M; Phillips TR Vaccine; 2001 Dec; 20(5-6):771-88. PubMed ID: 11738741 [TBL] [Abstract][Full Text] [Related]
25. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829 [TBL] [Abstract][Full Text] [Related]
26. Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1. Schwenk R; Banania G; Epstein J; Kim Y; Peters B; Belmonte M; Ganeshan H; Huang J; Reyes S; Stryhn A; Ockenhouse CF; Buus S; Richie TL; Sedegah M Malar J; 2013 Oct; 12():376. PubMed ID: 24168370 [TBL] [Abstract][Full Text] [Related]
27. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections. Whitacre DC; Espinosa DA; Peters CJ; Jones JE; Tucker AE; Peterson DL; Zavala FP; Milich DR PLoS One; 2015; 10(5):e0124856. PubMed ID: 25933001 [TBL] [Abstract][Full Text] [Related]
28. Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. del Guercio MF; Alexander J; Kubo RT; Arrhenius T; Maewal A; Appella E; Hoffman SL; Jones T; Valmori D; Sakaguchi K; Grey HM; Sette A Vaccine; 1997 Mar; 15(4):441-8. PubMed ID: 9141216 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE Malar J; 2013 Apr; 12():136. PubMed ID: 23607541 [TBL] [Abstract][Full Text] [Related]
30. Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge. Schwenk R; Lumsden JM; Rein LE; Juompan L; Kester KE; Heppner DG; Krzych U Vaccine; 2011 Nov; 29(48):8847-54. PubMed ID: 21983360 [TBL] [Abstract][Full Text] [Related]
31. Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A. Geiger KM; Guignard D; Yang C; Bikorimana JP; Correia BE; Houard S; Mkindi C; Daubenberger CA; Spertini F; Corradin G; Audran R Front Immunol; 2020; 11():412. PubMed ID: 32210975 [TBL] [Abstract][Full Text] [Related]
32. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. Gordon DM; McGovern TW; Krzych U; Cohen JC; Schneider I; LaChance R; Heppner DG; Yuan G; Hollingdale M; Slaoui M J Infect Dis; 1995 Jun; 171(6):1576-85. PubMed ID: 7769295 [TBL] [Abstract][Full Text] [Related]
33. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP). Sedegah M; Kim Y; Ganeshan H; Huang J; Belmonte M; Abot E; Banania JG; Farooq F; McGrath S; Peters B; Sette A; Soisson L; Diggs C; Doolan DL; Tamminga C; Villasante E; Hollingdale MR; Richie TL Malar J; 2013 Jun; 12():185. PubMed ID: 23738590 [TBL] [Abstract][Full Text] [Related]
34. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. Sun P; Schwenk R; White K; Stoute JA; Cohen J; Ballou WR; Voss G; Kester KE; Heppner DG; Krzych U J Immunol; 2003 Dec; 171(12):6961-7. PubMed ID: 14662904 [TBL] [Abstract][Full Text] [Related]
35. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C; Doolan DL Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242 [TBL] [Abstract][Full Text] [Related]
36. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge. Hutchings CL; Birkett AJ; Moore AC; Hill AV Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809 [TBL] [Abstract][Full Text] [Related]
37. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919 [TBL] [Abstract][Full Text] [Related]
38. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences. Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967 [TBL] [Abstract][Full Text] [Related]
39. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. Epstein JE; Charoenvit Y; Kester KE; Wang R; Newcomer R; Fitzpatrick S; Richie TL; Tornieporth N; Heppner DG; Ockenhouse C; Majam V; Holland C; Abot E; Ganeshan H; Berzins M; Jones T; Freydberg CN; Ng J; Norman J; Carucci DJ; Cohen J; Hoffman SL Vaccine; 2004 Apr; 22(13-14):1592-603. PubMed ID: 15068840 [TBL] [Abstract][Full Text] [Related]
40. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex. Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]